Source: ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Jing Wang, Melissa Lesko, Michelle H. Badri, Bianca C. Kapoor, Benjamin G. Wu, Yonghua Li, Gerald C. Smaldone, Richard Bonneau, Zachary D. Kurtz, Rany Condos, Leopoldo N. Segal. Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-?. ERJ Open Res, 3 (3) 00008-2017; 10.1183/23120541.00008-2017

Member's Comments

No comment yet.

Related content which might interest you: Microbes mediated host innate immune response in idiopathic pulmonary fibrosis Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Inhalation therapy of interferon-gamma in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 266s Year: 2005 Evasion of COPD in smokers: at what price? Source: Eur Respir J 2012; 39: 1298-1303 Year: 2012 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Pulmonary and systemic inflammatory response in patients with pulmonary infections receiving long-term glucocorticoid therapy Source: Eur Respir J 2002; 20: Suppl. 38, 15s Year: 2002 The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 Year: 2018 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 The pulmonary microbiome and immunological activity in IPF patients. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Mechanisms of impaired anti-bacterial Th1 responses in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016 Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Could pulmonary tuberculosis present without any inflammatory response? Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 Is lung emphysema in COPD patients reflected by central airways inflammation? Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003 Oral commensals in the lower airways of COPD leads to an altered host immune tone Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020